Fiche du document
2019
- doi: 10.3389/fcimb.2019.00019
- issn: 2235-2988
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcimb.2019.00019
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/30792970
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2235-2988
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_7E4799E9694B1
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Field guides Keys (Identification guides) Identification guides Speciation (Biology) Forensic identificationCiter ce document
M. Delavy et al., « Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays. », Serveur académique Lausannois, ID : 10.3389/fcimb.2019.00019
Métriques
Partage / Export
Résumé
Half of invasive fungal infections lead to death. Amongst pathogenic fungi, the most widespread species belong to the Candida genus and vary in their susceptibility to antifungal drugs. The emergence of antifungal resistance has become a major clinical problem. Therefore, the definition of susceptibility patterns is crucial for the survival of patients and the monitoring of resistance epidemiology. Although, most routinely used methods of AntiFungal Susceptibility Testing (AFST) have reached their limits, the rediscovery of Matrix Associated Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) in the field of mycology provides a promising alternative for the study of antifungal resistance. MALDI-TOF MS is already used in mycology for fungal identification, which permits to highlight inherent antifungal resistance. However, the main concern of clinicians is the rise of acquired antifungal resistance and the time needed for their detection. For this purpose, MALDI-TOF MS has been shown to be an accurate tool for AFST, presenting numerous advantages in comparison to commonly used techniques. Finally, MALDI-TOF MS could be used directly to detect resistance mechanisms through typing. Consequently, MALDI-TOF MS offers new perspectives in the context of healthcare associated outbreaks of emerging multi-drug resistant fungi, such as C. auris. As a proof of concept, we will illustrate the current and future benefits in using and adapting MALDI-TOF MS-based assays to define the susceptibility pattern of C. auris, by species identification, AFST, and typing.